Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125338161 | 12533816 | 1 | I | 20160225 | 20160226 | 20160706 | 20160706 | PER | US-PURDUE-USA-2016-0129302 | PURDUE | 0.00 | M | Y | 0.00000 | 20160706 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125338161 | 12533816 | 1 | PS | BUTRANS | BUPRENORPHINE | 1 | Transdermal | 10 MCG/HR, WEEKLY | 3040345B | 21306 | TRANSDERMAL PATCH | ||||||||
| 125338161 | 12533816 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | U | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125338161 | 12533816 | 1 | Analgesic therapy |
| 125338161 | 12533816 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125338161 | 12533816 | Dizziness | |
| 125338161 | 12533816 | Inadequate analgesia | |
| 125338161 | 12533816 | Insomnia | |
| 125338161 | 12533816 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125338161 | 12533816 | 1 | 20160225 | 0 |